Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-04
2009-12-29
Romeo, David S (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C514S013800, C514S014800, C514S016700, C530S326000, C530S327000, C530S329000, C530S330000, C530S350000
Reexamination Certificate
active
07638495
ABSTRACT:
The present invention relates to compositions comprising excipients or solubilizing agents for proteins. The invention relates to the discovery that a peptide derived from the N-terminus extension of the T266 isoform of rhBMP-2 has properties that enhance the solubility of proteins. The invention also relates to methods of resolubilizing a protein that has precipitated, by contacting the protein with a peptide comprised of the 17 amino acid extension of the T266 isoform of rhBMP-2. The invention also relates to methods of increasing the solubility of a protein by contacting the protein with a peptide comprised of the 17 amino acid extension of the T266 isoform of rhBMP-2.
REFERENCES:
patent: 4877864 (1989-10-01), Wang et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5079231 (1992-01-01), Brunetti et al.
patent: 5106748 (1992-04-01), Wozney et al.
patent: 5108922 (1992-04-01), Wang et al.
patent: 5116738 (1992-05-01), Wang et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5187076 (1993-02-01), Wozney et al.
patent: 5413914 (1995-05-01), Frnazusoff
patent: 5627043 (1997-05-01), Franzusoff
patent: 5635375 (1997-06-01), Kraus et al.
patent: 5637480 (1997-06-01), Celeste et al.
patent: 5639638 (1997-06-01), Wozney et al.
patent: 5658882 (1997-08-01), Celeste et al.
patent: 5661007 (1997-08-01), Wozney et al.
patent: 5674844 (1997-10-01), Kuberasampath et al.
patent: 5688678 (1997-11-01), Hewick et al.
patent: 5700774 (1997-12-01), Hattersley et al.
patent: 5756457 (1998-05-01), Wang et al.
patent: 5922846 (1999-07-01), Cerletti et al.
patent: 7241740 (2007-07-01), Nichols et al.
patent: 0 949 335 (1999-10-01), None
Groppe et al., J. Biol. Chem. 273:29052-65 (1998).
International Search Report for PCT/US2003/025177, Dec. 29, 2005.
Rathore et al., Protein Sci. 4[Supp1.2] 443s (1995).
Wozney et al., Science, 242:1528-1534 (1988).
International Preliminary Examination Report, PCT/US03/25177, Dec. 15, 2005.
Wozney et al. “Novel Regulators of Bone Formation: Molecular Clones and Activities.” Science, 242:1528-1530 (1988).
Kubler et al. (1998) “Inductive properties of recombinant human BMP-2 produced in a bacterial expression system,”Int. J. Oral Maxillofac. Surg. 27:305-309.
Supplementary European Search Report for EP 03 78 5215, dated Jun. 3, 2009.
Ebendal et al., “Bone Morphogenetic Proteins and Their Receptors: Potential Functions in the Brain,”J. Neurosci. Res. 51:139-146 (1998).
Reddi, “Role of morphogenetic proteins in skeletal tissue engineering and regeneration,”Nat. Biotechnol. 16:247-252 (1998).
Wozney, “Bone Morphogenetic Proteins,”Prog. Growth Factor Res. 1:267-280 (1989).
Nichols Pilarin Elizabeth Louise
Perez-Ramirez Bernardo
Finnegan Henderson Farabow Garrett & Dunner LLP
Romeo David S
Wyeth
LandOfFree
Peptides as solubilizing excipients for transforming growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides as solubilizing excipients for transforming growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides as solubilizing excipients for transforming growth... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4144801